Onkologie. 2009:3(4):231-234

Diagnosis and treatment of invasive fungal infections in patients with hematological malignancies

Ľuboš Drgoňa
II. onkologická klinika LF UK a Oddelenie klinickej hematológie, Interná klinika NOÚ, Bratislava

Recent basic knowledge on epidemiology, clinical features and diagnostic procedures of invasive fungal infections in hemato-oncology

is mentioned in the article. Recommendation of antifungal therapy based on up-to-date international and national consensus guidelines

are presented.

Keywords: invasive fungal infections, invasive aspergillosis, invasive candidiasis, candidaemia, antifungal therapy.

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drgoňa Ľ. Diagnosis and treatment of invasive fungal infections in patients with hematological malignancies. Onkologie. 2009;3(4):231-234.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality. Clin Infect Dis 2007; 44: 531-540. Go to original source... Go to PubMed...
    2. Mc Neil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33: 641-647. Go to original source... Go to PubMed...
    3. Pagano L, Caira L, Candoni A, et al. Haematologica 2006; 91: 1068-1075.
    4. Nath DS, Kandaswamy R, Gruessner R, et al. Fungal infections in transplant recipients receiving alemtuzumab. Transplant Proc. 2005; 37: 934-936. Go to original source... Go to PubMed...
    5. Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43, Suppl 1: S49-58. Go to original source... Go to PubMed...
    6. Steinbach WJ, Benjamin DK, Kontoyiannis DP, et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004; 39: 192-198. Go to original source... Go to PubMed...
    7. Gavaldá J, Len O, Rovira M, et al. Epidemiology of Invasive Fungal Infections (IFI) in Solid Organ (SOT) and Hematopoeitic Stem Cell (HSCT) Transplant Recipients: a Prospective Study from RESITRA. (Abstract M-990) In: Program and Abstracts of the 46th ICAAC, San Francisco, CA. American Society for Microbiology, 2006.
    8. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163. Go to original source... Go to PubMed...
    9. Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317-322. Go to original source... Go to PubMed...
    10. Drgona L, Trupl J, Roidova A, et al. Fungaemia in Slovakia: a prospective, national study. ECCMID 2008, Barcelona. P1571.
    11. Greenberg RN, Scott LJ, Vaughn HH, et al. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004; 17: 517-525. Go to original source... Go to PubMed...
    12. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653. Go to original source... Go to PubMed...
    13. Siwek GT, Dodgson KJ, De Magalhaes M, et al. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 2004; 39: 584-587. Go to original source... Go to PubMed...
    14. The Mycology Initiative Program - Opportunistic Fungi in the Immunocompromised Patient. The International Immunocompromised Host Society and the University of Pittsburg School of Medicine, 2001: 26.
    15. Patterson TJ, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Medicine (Baltimore) 2000; 79: 250-260. Go to original source... Go to PubMed...
    16. Pagano L, Mele L, Fianchi L, et al. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes. Haematologica 2002; 87: 535-541. Go to PubMed...
    17. Brodoefel H, Vogel M, Einsele H, et al. Long term CTfollow-up in 40 non-HIV immunocompromised patients with invasive pulmonary aspergillosis: kinetics of CT morphology and correlation with clinical findings and outcome. Am J Roentgenol 2006; 187: 404-413. Go to original source... Go to PubMed...
    18. Ráčil Z, Kocmanová I, Wagnerová B, et al. Časná diagnostika invazivních mykotických infekcí u hematoonkologických nemocných pomocí sérologických metod. Vnitř lék 2007; 53: 645-654.
    19. Haber J, Mallátová N, Kocmanová I. Invazivní mykózy. Epidemiologie, diagnostika, léčba. Pfizer 2007: 36. Go to original source... Go to PubMed...
    20. Drgoňa Ľ, Mikula J, Trupl J, et al. Diagnostika a liečba invazívnych mykóz. Antibiotiká a rezistencia 2008.
    21. Herbrecht R, Fluckiger U, Gachot B, et al. Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients. European Journal of Cancer Supplements. Guidelines from the First European Conference on Infections in Leukaemia: ECIL1 2007; 5: 49-59. Go to original source...
    22. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360. Go to original source... Go to PubMed...
    23. Herbrecht R, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. NEJM 2002; 347: 408-415. Go to original source... Go to PubMed...
    24. Caillot D, Mannone L, Cuisenier B, et al. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis. Clin Microbiol Infect 2001; 7, (suppl. 2): 54-61. Go to original source... Go to PubMed...
    25. Walsh TJ. Echinocandins: an advance in the primary treatment of invasive candidiasis NEJM 2002, 347, 5: 2001. Go to original source... Go to PubMed...
    26. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004; 38: 161-189. Go to original source... Go to PubMed...
    27. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006; 50(1): 126-133. Go to original source... Go to PubMed...
    28. Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008; 46: 201-211. Go to original source... Go to PubMed...
    29. Smith J, Safdar N, Knasinski V, et al. Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother 2006; 50: 1570-1572. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.